Eye Center of Northern Colorado, P.C.
1 clinical trials · Sponsor
◉ Watch Eye Center of Northern Colorado, P.C.
| Record | Firm | Date |
|---|---|---|
| High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia (NCT01205035) | Eye Center of Northern Colorado, P.C. | 2010-10-01 |
Track Eye Center of Northern Colorado, P.C. automatically
Every clearance here is in the API, with alerts when new ones post.